scholarly journals Therapy of bacterial vaginosis

2019 ◽  
pp. 104-109
Author(s):  
O. I. Marushkina
Keyword(s):  
Bacterial Vaginosis ◽  
Pregnant Women ◽  
Clinical Laboratory ◽  
Reproductive Age ◽  
Laboratory Methods ◽  
Anaerobic Microorganisms ◽  
Second Stage ◽  
Complex Therapy ◽  
Ph Level ◽  
Effective Remedy

Aim:evaluation of efficacy of Multi-Gyn® Actigel application in the complex therapy of bacterial vaginosis (BV) and prevention of its recurrence in pregnant women.Patients and methods:87 patients of reproductive age were examined and treated with the diagnosis of «bacterial vaginosis, chronic recurrent course». 41 of them from the main group were given Multi-Gyn® Actigel at the 1st stage of treatment, while 46 women of the comparison group were given 2% clindamycin cream In order to restore vaginal microbiocenosis, a probiotic containing Lactobacillus casei rhamnosus spp. LCR35 was used in both groups at the second stage Clinical laboratory methods were used.Results:efficacy of Multi-Gyn® Actigel application in complex therapy of BV and prevention of its recurrences in non-pregnant women was proved. As a result of Multi-Gyn® Actigel prescription there were no complaints, pH level was normalized, almost complete absence of BV-associated microorganisms was achieved and lactobacillus pool preservation even in the distant period after treatment.Conclusion:Multi-Gyn® Actigel is an effective remedy for treatment of BV and prevention of its recurrence in non-pregnant patients, especially in the chronic recurrent course of the disease. This effect is achieved not only by eliminating anaerobic microorganisms, but also due to the persistent preservation of the lactobacillus pool.

scholarly journals The features of complex therapy of bacterial vaginosis in pregnant women with cervical incompetence

2020 ◽  
Vol 0 (54) ◽  
pp. 55-62
Author(s):  
Д. Г. Коньков ◽  
Н. В. Адамчук ◽  
В. В. Кливак
Keyword(s):  
Bacterial Vaginosis ◽  
Pregnant Women ◽  
Cervical Incompetence ◽  
Complex Therapy

Diagnosis and therapy of bacterial vaginosis in pregnancy

2014 ◽  
Vol 5 (3) ◽  
pp. 88-95 ◽  
Author(s):  
Kira Valentinovna Shalepo ◽  
Veronika Viktorovna Nazarova ◽  
Yuliya Nikolayevna Menukhova ◽  
Yelena Vasilyevna Shipitsyna ◽  
Alevtina Mikhailovna Savicheva
Keyword(s):  
Reproductive Health ◽  
Health Outcomes ◽  
Bacterial Vaginosis ◽  
Pregnant Women ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
Diagnosis And Therapy ◽  
In Pregnancy

Bacterial vaginosis (BV) is the most common vaginal disorder in women of reproductive age. This review presents literature data regarding a role of BV in adverse reproductive health outcomes, describes current methods used for BV diagnosis and issues of treatment of this disease in pregnant women.

Comparison of the BD Affirm VPIII Test to Primary Care and Clinical Laboratory Methods for the Diagnosis of Bacterial Vaginosis and Yeast Vaginitis

2011 ◽  
Vol 19 (4) ◽  
pp. 273-275 ◽  
Author(s):  
Arthur E. Crist ◽  
David Bankert ◽  
Roslyn V. Mallory ◽  
Elliot L. Rank ◽  
Michelle Althouse
Keyword(s):  
Primary Care ◽  
Bacterial Vaginosis ◽  
Clinical Laboratory ◽  
Laboratory Methods

scholarly journals Bacterial Vaginosis in Pregnant Women Receiving Care at Maxixe Health Centre

2019 ◽  
Vol 4 (2) ◽  
Keyword(s):  
Risk Factors ◽  
Bacterial Vaginosis ◽  
Pregnant Women ◽  
Correct Diagnosis ◽  
Health Centre ◽  
Reproductive Age ◽  
African Countries ◽  
Multiple Partners ◽  
Increased Risk ◽  
Sub Saharan

Bacterial Vaginosis is a vaginal infection that occurs when there is a change in the balance of the vaginal flora with vaginal discharge, which may or may not have a characteristic smell, a decrease in vaginal pH, and it is one of the most common public health problems in Sub-Saharan African countries in women in reproductive age. Premature birth, underweight newborns and increased risk of HIV infection are some of its consequences. In Sub-Saharan countries like Mozambique, the real prevalence of this infection is almost unknown. Thus, this study was developed with the aim of analyzing the prevalence of bacterial vaginosis in pregnant women receiving care in the Maxixe City Health Centre (CSM) and identifying the risk factors associated with it. 253 samples of pregnant women attending prenatal external consultations at CSM were used in this study. Samples of vaginal exudate were obtained, stained by the Gram method and observed microscopically using the Nugent method to identify the bacterial vaginosis. The prevalence of bacterial vaginosis was 12, 3%, and the highest prevalence was recorded in the age group of 15-24. In this population, the inconsistent use of condom in sexual intercourse and multiple partners may be the risk factors in acquiring this infection. Therefore, it is concluded that the knowledge of etiology, correct diagnosis and appropriate treatment of bacterial vaginosis may contribute to a more comprehensive prenatal examination, aiming to reduce the rates of bacterial vaginosis and its consequences in pregnancy

scholarly journals Bacterial vaginosis: Prevalence and associated risk factors among non-pregnant women of reproductive age attending a Nigerian tertiary hospital

2018 ◽  
Vol 29 (4) ◽  
pp. 290 ◽  
Author(s):  
Rasheedat M. Abdullateef ◽  
Munirdeen A. Ijaiya ◽  
Fadeyi Abayomi ◽  
Abiodun S. Adeniran ◽  
Haruna Idris
Keyword(s):  
Risk Factors ◽  
Bacterial Vaginosis ◽  
Pregnant Women ◽  
Tertiary Hospital ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
Associated Risk Factors

Bacterial vaginosis in pregnancy: a current view on diagnosis and therapy (literature review)

GYNECOLOGY ◽  
2019 ◽  
Vol 21 (5) ◽  
pp. 30-34
Author(s):  
Tamara E Karapetyan ◽  
Natalya A Lomova ◽  
Valeria R Yusubova ◽  
Shota G Gvenetadze
Keyword(s):  
Bacterial Vaginosis ◽  
Pregnant Women ◽  
African American Women ◽  
Premature Birth ◽  
Genital Tract ◽  
Clinical Symptoms ◽  
Reproductive Age ◽  
Obstetric Outcomes ◽  
Current View ◽  
Increased Risk

Bacterial vaginosis (BV) is the most prevalent lower genital tract disease in women of reproductive age (both pregnant and non-pregnant) and the most common cause of vaginal discharge and foul odor from the genital tract. To date, there is a lot of literature describing many different approaches to the diagnosis and treatment of BV during pregnancy. BV is common, and its precise prevalence varies widely depending on the patient population. Studies confirm that the prevalence of BV among pregnant women is the same as in the population of non-pregnant women, and ranges from 6 to 32%. The link between BV and a patient’s ethnicity, smoking, sexual behavior and douching was established. BV is more prevalent among African American women, smokers, sexually active women compared to virgins and those who use douching. Diagnosis of BV is based on clinical symptoms and the results of microbiological examination. Diagnostic criteria are the same for pregnant and non-pregnant women. If BV is confirmed, treat-ment is indicated. In most international guidelines on sexually transmitted infections, the use of either metronidazole 500 mg orally 2 times a day for 7 days, or clindamycin 300 mg orally 2 times a day for 7 days are recommended for the prevention of adverse obstetric outcomes. BV is considered as the risk factor for adverse obstetric outcomes, such as premature birth, premature rupture of membranes, spontaneous abortion, chorioamnionitis and postpartum infections, such as endometritis and infectious compli-cations in the area of the postoperative wound after cesarean section. Pregnant women with symptoms of BV are advised to be screened and treated to eliminate the symptoms. Treatment with oral or local antibiotics is acceptable to achieve recovery (cure) in pregnant women with a symptomatic course of BV and a low risk of adverse obstetric outcomes. Women without symptoms of BV and women without identified risk factors for preterm birth should not be routinely screened and treated for BV, while patients with an increased risk for premature birth may benefit from routine screening and treatment for BV.

Advantages of personalized therapies in the treatment of bacterial vaginosis in women reproductive age

2016 ◽  
pp. 131-136
Author(s):  
V.O. Tovstanovskyy ◽  
◽  
A.E. Alatorskih ◽  
Faranak Parsal ◽  
◽  
...  
Keyword(s):  
Bacterial Vaginosis ◽  
Reproductive Age
Sign in / Sign up

Export Citation Format

Share Document